Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
Q5F1R6
UPID:
DJC21_HUMAN
Alternative names:
DnaJ homolog subfamily A member 5; Protein GS3
Alternative UPACC:
Q5F1R6; Q3B7J9; Q6P086; Q6ZS43; Q86VC6
Background:
DnaJ homolog subfamily C member 21, also known as Protein GS3, plays a crucial role in cellular processes. It acts as a co-chaperone for HSP70, assisting in protein folding and stabilization. Additionally, it is involved in ribosomal RNA biogenesis, particularly in the maturation of the 60S subunit, by binding the precursor 45S rRNA. This protein's multifaceted role underscores its importance in maintaining cellular homeostasis.
Therapeutic significance:
DnaJ homolog subfamily C member 21 is linked to Bone marrow failure syndrome 3, a severe disorder characterized by pancytopenia and potentially accompanied by growth, neurological, and skin anomalies. Understanding the role of this protein could open doors to potential therapeutic strategies, offering hope for targeted treatments that could alleviate or even cure this debilitating condition.